# Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients

Study · id `cardio:ct-nct01061320` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01061320](<https://clinicaltrials.gov/study/NCT01061320>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01061320

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01061320. Randomized; double masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2010-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01061320, source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01061320, source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)
- Primary completion: 2010-10 (anticipated) (ClinicalTrials.gov record NCT01061320, source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)
- Completion: 2010-12 (anticipated) (ClinicalTrials.gov record NCT01061320, source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)
- Countries: Thailand (ClinicalTrials.gov record NCT01061320, source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01061320-2010-02-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
- Condition: Contrast Induced Nephropathy
- Intervention (Drug): alpha tocopherol
- Intervention (Drug): placebo
- Lead sponsor: Thammasat University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: c2e913f4c9762838f657089694a74424fafa3c6bb74b9c2fe2f4249dc4047262
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
